PowderJect looks for CEO (chief executive office) as founder steps back:
This article was originally published in Clinica
PowderJect Pharmaceuticals, a UK-based development stage gas jet needle-free injector company is to hire a new CEO, as Paul Drayson, the founder and presently chairman and CEO of the seven-year-old company relinquishes that title. Mr Drayson will remain executive chairman. The company came in for criticism recently when Wall Street Journal Europe (WSJE) commented on PowderJect's repeatedly lengthening forecasts of when it could launch its first product, a needleless injection of the anaesthetic lidocaine. The WSJE estimates launch could be delayed until 2003 at least.
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.